Hey, look who has a major conflict of interest. It’s Senator Evan Bayh (D-IN), who voted in favor of the Senate healthcare reform legislation early this morning. (You can tell Democrats are proud of their bill by the time of day the vote took place.)

Turns out his wife, Susan, serves on the board of insurance company Wellpoint.

Last week Sen. Evan Bayh’s office responded to my request for the senator’s thoughts on health-care reform. Bayh’s wife, Susan, is a board member at WellPoint.

Here are three questions I e-mailed his office: Does he support the legislation as it now stands? Does he support an expanded Medicare for those 55 or older? Did he support the public option being dropped from the legislation? (WellPoint has spoken against a public option and proposed Medicare buy-in.)

How did Bayh respond? By dodging the questions, as Brian Faughnan reports. Say, how has Wellpoint been doing as of late? Ah:

Shares of Indianapolis-based WellPoint have jumped about 8 percent so far this month. Cigna shares have risen 12 percent, UnitedHealth Group 10 percent and Humana 5 percent…

Health insurer stock prices rose in recent weeks as the prospects for a new “public option” government health plan and a proposed Medicare expansion faded (at least for now) from the reform debate.

The rally did not go unnoticed. Six executives or directors from WellPoint combined to sell more than $11 million in company shares Dec. 3-14, according to Thomson Financial.

It’s been known for quite some time that the Bayh family makes a pretty penny off Mrs. Bayh’s service on several corporate boards. In fact, the family is believed to be worth around $15 million largely due to said service.

Why does any of this matter? Bayh just voted in favor of legislation that requires millions of Americans, by law, to purchase insurance from private companies. That means potentially millions of additional customers for Wellpoint. His wife and her company stand to benefit greatly from Bayh’s vote.

More corruption in Washington? I know; you’re shocked.